Switch theme
Sign up to access all valuation multiples
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.
2015
378
Last FY Revenue $20.6M
Last FY EBITDA -$17.7M
$1.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, SS Innovations achieved revenue of $20.6M and an EBITDA of -$17.7M.
SS Innovations expects next 12-month revenue of XXX and NTM EBITDA of XXX
See SS Innovations valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $20.6M | XXX | XXX | XXX |
| Gross Profit | XXX | $8.5M | XXX | XXX | XXX |
| Gross Margin | XXX | 41% | XXX | XXX | XXX |
| EBITDA | XXX | -$17.7M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -86% | XXX | XXX | XXX |
| EBIT | XXX | -$19.0M | XXX | XXX | XXX |
| EBIT Margin | XXX | -92% | XXX | XXX | XXX |
| Net Profit | XXX | -$19.2M | XXX | XXX | XXX |
| Net Margin | XXX | -93% | XXX | XXX | XXX |
| Net Debt | XXX | $15.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 15, 2025, SS Innovations's stock price is $7.
SS Innovations has current market cap of $1.3B, and EV of $1.3B.
See SS Innovations trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.3B | $1.3B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 15, 2025, SS Innovations has market cap of $1.3B and EV of $1.3B.
SS Innovations's trades at 62.6x EV/Revenue multiple, and -72.9x EV/EBITDA.
Equity research analysts estimate SS Innovations's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
SS Innovations's P/E ratio is not available.
See valuation multiples for SS Innovations and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| EV (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 62.6x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -72.9x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -68.2x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -67.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -127.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSS Innovations's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
SS Innovations's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SS Innovations's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for SS Innovations and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -86% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 12% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 133% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SS Innovations acquired XXX companies to date.
Last acquisition by SS Innovations was XXXXXXXX, XXXXX XXXXX XXXXXX . SS Innovations acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was SS Innovations founded? | SS Innovations was founded in 2015. |
| Where is SS Innovations headquartered? | SS Innovations is headquartered in United States of America. |
| How many employees does SS Innovations have? | As of today, SS Innovations has 378 employees. |
| Who is the CEO of SS Innovations? | SS Innovations's CEO is Dr. Vishwajyoti P. Srivastava, M.D.. |
| Is SS Innovations publicy listed? | Yes, SS Innovations is a public company listed on NAS. |
| What is the stock symbol of SS Innovations? | SS Innovations trades under SSII ticker. |
| When did SS Innovations go public? | SS Innovations went public in 2018. |
| Who are competitors of SS Innovations? | Similar companies to SS Innovations include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of SS Innovations? | SS Innovations's current market cap is $1.3B |
| Is SS Innovations profitable? | Yes, SS Innovations is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
